Question to the Department of Health and Social Care:

To ask Her Majesty’s Government what is their assessment of the BCG vaccine treatment of bladder cancer.

We have made no such assessment.

The National Institute for Health and Care Excellence (NICE) is the independent body responsible for providing best practice guidance for the National Health Service.

NICE published a clinical guideline in February 2015 on the diagnosis and management of bladder cancer which outlines the circumstances in which the Bacille Calmette‑Guérin (BCG) vaccine should be used to treat bladder cancer. A copy of the clinical guideline is attached.

A bladder cancer quality standard was also published by NICE in December 2015 which refers to BCG treatment for bladder cancer. A copy of the quality standard is attached.